Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Local botulinum toxin in the treatment of spastic drop foot.
Dengler R, Neyer U, Wohlfarth K, Bettig U, Janzik HH. Dengler R, et al. Among authors: wohlfarth k. J Neurol. 1992 Aug;239(7):375-8. doi: 10.1007/BF00812153. J Neurol. 1992. PMID: 1403018
The use of botulinum toxin A for treatment of possible essential blepharospasm in a dog.
Meyer-Lindenberg A, Wohlfarth KM, Switzer EN. Meyer-Lindenberg A, et al. Among authors: wohlfarth km. Aust Vet J. 2003 Oct;81(10):612-4. doi: 10.1111/j.1751-0813.2003.tb12503.x. Aust Vet J. 2003. PMID: 15080472
Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: much ado about nothing?
Lange O, Bigalke H, Dengler R, Wegner F, deGroot M, Wohlfarth K. Lange O, et al. Among authors: wohlfarth k. Clin Neuropharmacol. 2009 Jul-Aug;32(4):213-8. doi: 10.1097/WNF.0b013e3181914d0a. Clin Neuropharmacol. 2009. PMID: 19620852
Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study.
Blersch W, Schulte-Mattler WJ, Przywara S, May A, Bigalke H, Wohlfarth K. Blersch W, et al. Among authors: wohlfarth k. J Neurol Sci. 2002 Dec 15;205(1):59-63. doi: 10.1016/s0022-510x(02)00313-1. J Neurol Sci. 2002. PMID: 12409185 Clinical Trial.
[Is the origin of the F-wave dependent on the magnitude of the motor unit?].
Wohlfarth K, Dengler R, Kossev A, Elek J, Schubert M, Wolf W. Wohlfarth K, et al. EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb. 1992 Sep;23(3):140-3. EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb. 1992. PMID: 1425390 German.
Botulinum A toxins: units versus units.
Wohlfarth K, Göschel H, Frevert J, Dengler R, Bigalke H. Wohlfarth K, et al. Naunyn Schmiedebergs Arch Pharmacol. 1997 Mar;355(3):335-40. doi: 10.1007/pl00004951. Naunyn Schmiedebergs Arch Pharmacol. 1997. PMID: 9089663 Clinical Trial.
Biological activity of two botulinum toxin type A complexes (Dysport and Botox) in volunteers: a double-blind, randomized, dose-ranging study.
Wohlfarth K, Schwandt I, Wegner F, Jürgens T, Gelbrich G, Wagner A, Bogdahn U, Schulte-Mattler W. Wohlfarth K, et al. J Neurol. 2008 Dec;255(12):1932-9. doi: 10.1007/s00415-008-0031-7. Epub 2008 Oct 7. J Neurol. 2008. PMID: 18854916 Clinical Trial.
Treatment of habitual snoring with botulinum toxin: a pilot study.
Kühnel TS, Schulte-Mattler W, Bigalke H, Wohlfarth K. Kühnel TS, et al. Among authors: wohlfarth k. Sleep Breath. 2008 Mar;12(1):63-8. doi: 10.1007/s11325-007-0136-8. Sleep Breath. 2008. PMID: 17882462 Clinical Trial.
Neutralizing botulinum toxin type a antibodies: clinical observations in patients with cervical dystonia.
Rollnik JD, Wohlfarth K, Dengler R, Bigalke H. Rollnik JD, et al. Among authors: wohlfarth k. Neurol Clin Neurophysiol. 2001;2001(3):2-4. doi: 10.1162/152687401300343571. Neurol Clin Neurophysiol. 2001. PMID: 12396862 Clinical Trial.
Remote F-wave changes after local botulinum toxin application.
Wohlfarth K, Schubert M, Rothe B, Elek J, Dengler R. Wohlfarth K, et al. Clin Neurophysiol. 2001 Apr;112(4):636-40. doi: 10.1016/s1388-2457(01)00478-3. Clin Neurophysiol. 2001. PMID: 11275536
47 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback